Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Simendan MeSH Descriptor Data 2026


MeSH Heading
Simendan
Tree Number(s)
D02.442.288.610
D03.383.710.802
Unique ID
D000077464
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077464
Scope Note
A hydrazone and pyridazine derivative; the levo-form is a phosphodiesterase III inhibitor, calcium-sensitizing agent, and inotropic agent that is used in the treatment of HEART FAILURE.
Entry Term(s)
((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
Dextrosimendan
Levosimendan
OR 1259
OR-1259
OR-1855
Simadax
Pharm Action
Cardiotonic Agents
Vasodilator Agents
Phosphodiesterase 3 Inhibitors
Registry Numbers
349552KRHK
C6T4514L4E
0
Related Numbers
131741-08-7
C6T4514L4E
CAS Type 1 Name
Propanedinitrile, 2-(2-(4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazinylidene)-
Public MeSH Note
2019; SIMENDAN was indexed under HYDRAZONES and PYRIDAZINES 1992-2018
History Note
2019 (1992)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Simendan Preferred
Levosimendan Narrower
OR 1259 Narrower
Dextrosimendan Narrower
OR-1855 Narrower
Simadax Narrower
page delivered in 0.148s